{"title":"用于新药设计的等变量三维条件扩散模型","authors":"Jia Zheng, Hai-Cheng Yi, Zhu-Hong You","doi":"10.1109/JBHI.2024.3491318","DOIUrl":null,"url":null,"abstract":"<p><p>De novo drug design speeds up drug discovery, mitigating its time and cost burdens with advanced computational methods. Previous work either insufficiently utilized the 3D geometric structure of the target proteins, or generated ligands in an order that was inconsistent with real physics. Here we propose an equivariant 3D-conditional diffusion model, named DiffFBDD, for generating new pharmaceutical compounds based on 3D geometric information of specific target protein pockets. DiffFBDD overcomes the underutilization of geometric information by integrating full atomic information of pockets to backbone atoms using an equivariant graph neural network. Moreover, we develop a diffusion approach to generate drugs by generating ligand fragments for specific protein pockets, which requires fewer computational resources and less generation time (65.98% ∼ 96.10% lower). DiffFBDD offers better performance than state-of-the-art models in generating ligands with strong binding affinity to specific protein pockets, while maintaining high validity, uniqueness, and novelty, with clear potential for exploring the drug-like chemical space. The source code of this study is freely available at https://github.com/haichengyi/DiffFBDD.</p>","PeriodicalId":13073,"journal":{"name":"IEEE Journal of Biomedical and Health Informatics","volume":"PP ","pages":""},"PeriodicalIF":6.7000,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Equivariant 3D-Conditional Diffusion Model for De Novo Drug Design.\",\"authors\":\"Jia Zheng, Hai-Cheng Yi, Zhu-Hong You\",\"doi\":\"10.1109/JBHI.2024.3491318\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>De novo drug design speeds up drug discovery, mitigating its time and cost burdens with advanced computational methods. Previous work either insufficiently utilized the 3D geometric structure of the target proteins, or generated ligands in an order that was inconsistent with real physics. Here we propose an equivariant 3D-conditional diffusion model, named DiffFBDD, for generating new pharmaceutical compounds based on 3D geometric information of specific target protein pockets. DiffFBDD overcomes the underutilization of geometric information by integrating full atomic information of pockets to backbone atoms using an equivariant graph neural network. Moreover, we develop a diffusion approach to generate drugs by generating ligand fragments for specific protein pockets, which requires fewer computational resources and less generation time (65.98% ∼ 96.10% lower). DiffFBDD offers better performance than state-of-the-art models in generating ligands with strong binding affinity to specific protein pockets, while maintaining high validity, uniqueness, and novelty, with clear potential for exploring the drug-like chemical space. The source code of this study is freely available at https://github.com/haichengyi/DiffFBDD.</p>\",\"PeriodicalId\":13073,\"journal\":{\"name\":\"IEEE Journal of Biomedical and Health Informatics\",\"volume\":\"PP \",\"pages\":\"\"},\"PeriodicalIF\":6.7000,\"publicationDate\":\"2024-11-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"IEEE Journal of Biomedical and Health Informatics\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://doi.org/10.1109/JBHI.2024.3491318\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"COMPUTER SCIENCE, INFORMATION SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"IEEE Journal of Biomedical and Health Informatics","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1109/JBHI.2024.3491318","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"COMPUTER SCIENCE, INFORMATION SYSTEMS","Score":null,"Total":0}
Equivariant 3D-Conditional Diffusion Model for De Novo Drug Design.
De novo drug design speeds up drug discovery, mitigating its time and cost burdens with advanced computational methods. Previous work either insufficiently utilized the 3D geometric structure of the target proteins, or generated ligands in an order that was inconsistent with real physics. Here we propose an equivariant 3D-conditional diffusion model, named DiffFBDD, for generating new pharmaceutical compounds based on 3D geometric information of specific target protein pockets. DiffFBDD overcomes the underutilization of geometric information by integrating full atomic information of pockets to backbone atoms using an equivariant graph neural network. Moreover, we develop a diffusion approach to generate drugs by generating ligand fragments for specific protein pockets, which requires fewer computational resources and less generation time (65.98% ∼ 96.10% lower). DiffFBDD offers better performance than state-of-the-art models in generating ligands with strong binding affinity to specific protein pockets, while maintaining high validity, uniqueness, and novelty, with clear potential for exploring the drug-like chemical space. The source code of this study is freely available at https://github.com/haichengyi/DiffFBDD.
期刊介绍:
IEEE Journal of Biomedical and Health Informatics publishes original papers presenting recent advances where information and communication technologies intersect with health, healthcare, life sciences, and biomedicine. Topics include acquisition, transmission, storage, retrieval, management, and analysis of biomedical and health information. The journal covers applications of information technologies in healthcare, patient monitoring, preventive care, early disease diagnosis, therapy discovery, and personalized treatment protocols. It explores electronic medical and health records, clinical information systems, decision support systems, medical and biological imaging informatics, wearable systems, body area/sensor networks, and more. Integration-related topics like interoperability, evidence-based medicine, and secure patient data are also addressed.